5 best EDC platforms for pediatric clinical trials in 2026

A pediatric protocol rarely stays still. Age-banded dosing cohorts, caregiver-reported outcomes, and a consent process that has to satisfy both a parent and, often, the child's own assent all shift mid-study as enrollment reveals what the original design missed. Viedoc's electronic data capture (EDC) software handles that churn with a no-code Designer your data team runs in-house, flexible eCRFs built for age-specific assessments, and study builds typically completed in 8–12 weeks across 8,000-plus completed studies in 75-plus countries. This comparison reviews five EDC platforms for pediatric clinical trials across flexible form design, caregiver and proxy-reported data capture, consent and assent workflow support, and inspection readiness.

You're managing a population that can't complete adult-length questionnaires, sites that need caregiver logins alongside investigator access, and an ethics committee that will flag any consent flow that doesn't clearly separate parental permission from the child's own assent. Layer in dosing bands that shift by weight or age as your data comes in, and every mid-study amendment becomes a race against enrollment. The EDC you choose either absorbs that complexity or becomes the thing your team works around.

Enterprise platforms built for large adult Phase III programs assume a single consent signer, a fixed visit schedule, and a vendor programmer standing by for every change, none of which fit a protocol that adapts as cohorts age in. Academic or budget tools swing the other way, lacking the validation depth a regulated pediatric study needs. The platforms below are judged on age-specific data capture, flexible consent routing, and amendment speed, without the vendor-programmer dependency and multi-month build cycles legacy enterprise platforms still carry.

Best EDC platforms for pediatric clinical trials: quick comparison

These five eClinical platforms represent the most evaluated options for pediatric clinical trials, reviewed across flexible form design, caregiver and proxy-reported data capture, consent and assent workflow support, and inspection readiness.

1. Viedoc

Viedoc's EDC software gives your data management team direct, in-house control over study design through a no-code, drag-and-drop Designer, so age-banded visit schedules, weight-based dosing logic, and child-friendly eCRFs get built and amended without a vendor programmer. Study builds are typically completed in 8–12 weeks, with self-service setups going live in as little as one day for teams that configure their own studies. That flexibility matters when a pediatric protocol's age bands or dosing logic shift as enrollment fills each cohort.

For caregiver and proxy-reported data, Viedoc's ePRO software configures field types including visual analog scales, drawing pads, and free-text entry, so a parent or guardian can report on a young child's symptoms on their own device rather than a form built for an adult respondent. The same platform handles patient-, clinician-, and observer-reported outcomes without a separate system, keeping proxy and self-reported data together as a child ages through the study. Multinational programs also draw on support for 50-plus languages, reducing the friction of translating caregiver-facing instruments site by site.

Viedoc is ISO 27001 and SOC 2 certified and supports FDA 21 CFR Part 11, ICH GCP, GDPR, and HIPAA, hosted with 99.99% platform uptime. Its eSignature workflows let participants, guardians, and site personnel sign documents from their own devices under role-based access controls, with a complete audit trail from issuance to signature. Support runs 24/7 across global offices, which matters when a multi-site trial spans time zones and an amendment can't wait for the next business day.

That flexibility resonates with users too. "It offers customizable study workflow and tailoring it according to trial specification is easy," says Sanchita V., Data Manager.

Verified proof points:

• Study scale: 8,000+ studies run on Viedoc across 75+ countries
• User base: 140,000+ users globally; 30,000+ sites
• Build speed: Study builds typically completed in 8–12 weeks; self-service go-live in as little as one day
• Language support: Available in 50+ languages
• Compliance: FDA 21 CFR Part 11, ICH GCP, GDPR, HIPAA; ISO 27001 and SOC 2 certified
• Support: 24/7 customer success across global offices

2. Medidata

Medidata offers Rave EDC, the electronic data capture system at the core of the Medidata Clinical Cloud, an integrated platform spanning study design, data capture, and safety reporting. Rave EDC supports protocol amendments and mid-study changes without system downtime, and AI-assisted configuration tools aim to reduce time spent on repetitive study-build tasks. The platform connects to adjacent Medidata applications including eConsent, eCOA, and randomization and trial supply management (RTSM), and Rave Companion populates EDC forms directly from electronic health record data to reduce site re-entry. Medidata also offers Rave Lite, a simplified configuration positioned for Phase I, Phase IV, and medical device post-market studies. Rave EDC is used across large pharmaceutical, biotech, and CRO organizations running trials of varying phase and complexity.

3. Veeva

Veeva offers Veeva EDC, a module of the Veeva Clinical Platform built on a point-and-click Studio design environment that avoids custom scripting for most study builds. The platform reports database builds around 50% faster than legacy alternatives, with amendments applied to active studies without downtime or data migrations. Veeva EDC connects natively to Veeva RTSM, Vault CTMS, Vault eTMF, and Veeva DQS within a single connected clinical platform, and supports local lab data management and DICOM imaging review in the same environment. The platform serves biopharmaceutical companies, CROs, and MedTech organizations running studies of varying complexity, and its broader clinical suite is positioned for sponsors already standardized on the Vault ecosystem.

4. Castor EDC

Castor EDC is a cloud-native electronic data capture and clinical data management platform built around a low-code eCRF builder designed for users without deep technical expertise. The company reports deploying low-complexity studies in as little as 3–4 weeks and ranks among the top 5% of EDC providers for shortest platform build time. Castor integrates EDC, eCOA/ePRO, and eConsent on a single unified database, so patient-reported and clinical data share one record rather than requiring reconciliation between systems, and its open API connects to EHR, laboratory, and wearable data sources. The platform is validated for FDA 21 CFR Part 11, GDPR, ISO 27001, EU Annex 11, and ICH GCP, serving pharmaceutical, biotech, CRO, academic, and medical device organizations across more than 170 countries.

5. Medrio

Medrio provides a cloud-based electronic data capture and clinical data management system (CDMS) configured through a code-free interface, with study-copy functionality that lets teams reuse existing designs. The platform supports faster database lock and mid-study changes tested before going live, without requiring a programmer for routine configuration. Medrio's suite includes ePRO/eCOA, eConsent, randomization and trial supply management (RTSM), and both online and offline data capture for sites with inconsistent connectivity. The company reports more than 20 years of clinical use across thousands of completed studies, with dedicated project management and clinical data services available for builds and analysis. Medrio primarily serves CROs and smaller biotech, pharma, and medical device sponsors running early-phase and moderate-complexity trials.

What to look for in EDC solutions for pediatric clinical trials

Flexible form design for age-banded and proxy-reported data

Pediatric trials collect data across multiple age bands, sometimes reported by the child directly and sometimes by a caregiver acting as proxy, and a rigid form structure forces the same questionnaire design onto both. Best-in-class platforms offer configurable field types, including visual scales, drawing pads, and conditional visibility, that adapt to age and respondent type within a single study rather than requiring a separate build for each cohort. Miss this and your team ends up managing parallel study designs, or manually adapting adult-style forms that produce inconsistent data across age bands.

Consent and assent workflow support

A pediatric protocol typically needs a parent or guardian's informed consent and, depending on age and jurisdiction, the child's own assent captured separately, and a platform built around a single adult signer doesn't map cleanly onto that. Best-in-class means eConsent software with role-based signer permissions that route documents to the appropriate signer on the participant's own device, backed by a complete audit trail from issuance to signature. Get this wrong and a study either falls back to paper workarounds for edge cases or builds a process an ethics committee flags during review.

Amendment speed as cohorts age into new dosing bands

Age- and weight-based dosing bands mean the protocol itself often changes as enrollment fills each cohort, and every amendment has to reach live sites without pausing data collection. Best-in-class is no-code configuration that lets your own data manager apply changes in-house within days rather than queuing for vendor programming. A platform that needs a vendor ticket for routine dosing-band changes will throttle enrollment just as a cohort opens.

Audit trail and inspection readiness under added regulatory scrutiny

Pediatric protocols attract additional scrutiny from ethics committees and regulators overseeing a vulnerable population, so the audit trail has to withstand a level of review adult studies don't always face. Best practice is a field-level audit trail validated to recognized standards, paired with structured inspection-readiness documentation available before an auditor asks for it. Treat this as secondary and the gap surfaces during ethics or regulatory review, when there's no time left to fix it.

Data quality tools for small, high-value cohorts

Pediatric enrollment is often slow and cohorts stay small, so every data point carries more analytical weight than in a large adult trial. Best-in-class means real-time validation at entry, live dashboards tracking enrollment and query status, and integrated ePRO/eCOA that avoids a separate system requiring manual reconciliation.

How to choose the right EDC solution for pediatric clinical trials

Step 1: Define your respondent mix across age bands

Map out which age bands in your protocol will self-report, which will rely on a caregiver proxy, and where that handoff happens as a child ages during the study. This single decision shapes whether you need a platform that can switch respondent type mid-study without a redesign.

Step 2: Assess who owns consent and assent routing

Confirm whether your platform can route a document to a parent or guardian for consent and, separately, to the child for assent, with both actions captured in one audit trail. A platform that treats every signer identically forces manual workarounds your ethics committee is likely to question.

Step 3: Scrutinize amendment turnaround against your dosing schedule

Price out how long a dosing-band or visit-schedule change takes on each platform you're evaluating, against how often your protocol is likely to amend as cohorts fill. A platform that scores well on initial build speed but needs vendor programming for every subsequent change will still slow you down mid-study.

Step 4: Evaluate inspection readiness before ethics review, not after

Ask to see the audit trail at field level and confirm what inspection-readiness documentation the vendor provides as standard, before your protocol reaches ethics or regulatory review. The time to discover a gap is during evaluation, not once a reviewer has raised it.

Step 5: Choose a platform built for evolving cohorts

Weigh how each platform fits the way a pediatric study actually runs: whether your own team can build and amend it as cohorts age in, whether consent and assent routing map to your protocol, and whether support keeps pace with a multi-site, multi-time-zone trial. Viedoc's EDC software is built around this profile, with in-house no-code configuration, flexible caregiver and proxy data capture, and 24/7 support, and if that matches your pediatric program, you can book a demo or request a proposal to see it against your own protocol.

Frequently asked questions

What is the best EDC platform for pediatric clinical trials?

Viedoc's EDC software is the strongest fit for pediatric clinical trials, with a no-code Designer your team runs in-house, flexible eCRFs that switch between self-reported and caregiver-proxy data, and study builds typically completed in 8–12 weeks. That combination of in-house control and flexible form design suits protocols that adapt as cohorts age through a study. Medrio is a credible alternative for CROs and smaller sponsors running early-phase pediatric or device studies, and Castor EDC offers a unified EDC, ePRO, and eConsent database with fast low-complexity builds. Medidata and Veeva remain strong for large, multi-region pediatric programs within a broader adult portfolio.

What should you look for in an EDC platform for pediatric trials?

Prioritize flexible form design that adapts to age band and respondent type, consent and assent routing that separates a guardian's signature from a child's own assent, and amendment speed fast enough to keep pace with dosing-band changes as cohorts age in. Audit trail depth and inspection-readiness documentation matter more than usual, since pediatric protocols face added ethics and regulatory scrutiny. A platform that scores well on general usability but treats every signer and every respondent the same will create workarounds later in the study.

How long does it take to build and deploy a pediatric study on a modern EDC platform?

It depends on study complexity and whether you build in-house or through vendor-managed services, but modern no-code platforms have compressed timelines from months to weeks. Self-service teams can go live in as little as a day, while studies built through professional services typically take several weeks from signed work order to go-live. For Viedoc, that typically runs 8–12 weeks for managed builds. What matters most for pediatric protocols is how quickly a dosing-band or consent-flow amendment can go live once cohorts start aging in.

How does Viedoc support caregiver-reported and proxy outcomes in pediatric trials?

Viedoc's ePRO software configures field types including visual analog scales, drawing pads, and free-text entry, so a parent or guardian can report on a young child's behalf using a format suited to a proxy respondent rather than an adult questionnaire. Patient-, clinician-, and observer-reported outcomes run on the same platform, so proxy and self-reported data stay in one record as a child ages through the study and respondent type shifts. Support for 50-plus languages helps multinational pediatric programs deploy caregiver-facing instruments without a separate translation workflow per country. This data flows directly into the EDC database in real time, without manual reconciliation between systems.

What compliance and consent features matter most for a pediatric trial's EDC setup?

At minimum, expect FDA 21 CFR Part 11, ICH GCP, and GDPR compliance, a complete audit trail, and eConsent workflows that support role-based signer routing for both parental consent and child assent. Viedoc, for instance, is ISO 27001 and SOC 2 certified and provides the Viedoc Inspection Readiness Packet to every customer as standard, structured validation documentation. Confirm how a platform's eSignature workflow distinguishes a guardian's signature from a minor's assent before you build the study, not after an ethics committee asks. These features carry more weight in pediatric work than in an equivalent adult trial, given the added scrutiny a vulnerable population attracts.

How does Viedoc's study build time compare to Medidata's for pediatric protocols?

Viedoc and Medidata Rave EDC take different approaches to study build. Viedoc is configured in-house through a no-code Designer, with study builds typically completed in 8–12 weeks and mid-study amendments handled by your own data manager. Medidata Rave is generally configured by Medidata or its accredited implementation partners, which suits large, multi-region pediatric programs but can extend build and amendment timelines compared with a self-service model. For a smaller pediatric protocol that expects to amend dosing bands as cohorts age in, the in-house build model usually wins on speed and control.

Making the right EDC choice for pediatric clinical trials

The five platforms reviewed here share a common direction: cloud-based capture, configurable eCRFs, and integrated ePRO or eCOA modules that reduce the number of systems a study team manages. Where they diverge is weight and operating model, from enterprise suites built for large multi-region portfolios to lean, self-service platforms designed for smaller cohorts. The global eClinical software market sits above $11 billion in 2025 and continues to grow at roughly 14% a year, pushing vendors toward faster builds and more respondent-aware data capture.

Matching platform to profile comes down to a few variables: how many age bands your protocol spans, how often consent and assent routing needs to flex, your build cadence as cohorts open and close, and the regions your sites operate in. A program running frequent dosing-band amendments with a lean data team weights in-house configuration highest, while a group embedded in a larger sponsor portfolio may weight suite breadth and installed base more. US teams often prioritize speed and return on investment, while EU and APAC teams tend to weight compliance credentials more heavily.

Whatever you choose, the cost of switching an EDC platform mid-program is high, and the validation and retraining burden compounds across a multi-cohort pediatric study, so the platform that fits at the outset is usually cheaper over the life of the program than the one that looked cheapest at the first build.

Why Viedoc is the best EDC choice for pediatric clinical trials

For pediatric protocols, the platform that adapts as cohorts age in wins, and that's the problem Viedoc's EDC software is built to solve. Its no-code Designer puts age-banded visit schedules, dosing-logic changes, and child-friendly eCRFs in your data team's hands, with builds typically completed in 8–12 weeks and self-service setups live in as little as a day.

That flexibility carries through to caregiver and proxy-reported data, where configurable field types and multilingual support keep self-reported and proxy data in one record as respondent type shifts. eSignature workflows route consent and assent to the right signer on their own device, with a full audit trail behind every signature. For CROs building a pediatric practice, Viedoc's tiered CRO program adds a certified partner network to lean on as that portfolio grows.

The credentials hold up under added scrutiny. Viedoc is ISO 27001 and SOC 2 certified, compliant with FDA 21 CFR Part 11, ICH GCP, GDPR, and HIPAA, and backed by the Viedoc Inspection Readiness Packet available to every customer. It's a platform proven across 8,000-plus studies in 75-plus countries, built by a company working in clinical research since 2003.

If you want an EDC your own team can build, amend, and adapt as your pediatric cohorts evolve, Viedoc is designed for exactly that. Book a demo or request a proposal and the team will walk through flexible form design, consent and assent routing, and inspection readiness against your own pediatric portfolio.